<?xml version="1.0" encoding="UTF-8"?>
<TreatmentNodes>
    <TreatmentNode Type="Root" Label="B2. Telaprevir for prior partial or null responders or patients with cirrhosis">
        <TreatmentNode Type="TreatmentStep" Label="PEG-IFN/RBV + Telaprevir" Duration="4" Help="As part of telaprevir-based therapy, the patient begins peginterferon, ribavirin, and telaprevir simultaneously."></TreatmentNode>
        <TreatmentNode Type="DecisionPoint"
            Label="Week 4: &gt;= 1,000 IU/ml" Help="At the end of Week 4, the HCV RNA is measured. The Week 4 response determines whether or not to continue treatment.">
            <TreatmentNode Type="Parent" Value="0" Label="No"
                Text="&lt; 1,000 IU/ml">
                <TreatmentNode Type="TreatmentStep"
                    Label="PEG-IFN/RBV + Telaprevir" Duration="8" Help="The patient continues treatment with peginterferon, ribavirin and telaprevir.">
                </TreatmentNode>
                <TreatmentNode Type="DecisionPoint"
                    Label="Week 12: HCV RNA &gt;= 1,000 IU/ml" Help="At the end of Week 12, the HCV RNA is measured again. At this testing point you are checking to make sure the patient is not experiencing virologic failure, which at this point in the treatment (12 weeks in) means HCV RNA should be less than 1000 IU/ml.">
                    <TreatmentNode Type="Parent" Label="No" Value="0"
                        Text="HCV RNA &lt; 1,000 IU/ml">
                        <TreatmentNode Type="TreatmentStep"
                            Label="PEG-IFN/RBV" Duration="12" Help="Since the week 12 HCV RNA is &lt;=1000 IU/ml, the patient continues treatment with peginterferon and ribavirin. Telaprevir is never to be continued past 12 weeks of treatment. In the unusual circumstance that the patient's HCV RNA level is higher at week 12 then at week 4 (but still &lt;=1000 IU/ml), HCV RNA levels should be repeated to determine if the patient is breaking through treatment.">
                        </TreatmentNode>
                        <TreatmentNode Type="DecisionPoint"
                            Label="Week 24: HCV RNA Detected" Help="At the end of Week 24, the HCV RNA is measured again.">
                            <TreatmentNode Type="Parent" Value="0"
                                Label="No"
                                Text="HCV RNA not detected">
                                <TreatmentNode Type="TreatmentStep"
                                    Label="PEG-IFN/RBV" Duration="24" Help="Since the HCV RNA is not detected, the patient continues treatment with peginterferon and ribavirin to complete a total treatment duration of 48 weeks. The patient then stops all treatment. ">
                                </TreatmentNode>
                                <TreatmentNode Type="Stop"
                                    Label="Treatment Complete" Help="HCV RNA is measured after treatment is complete and again 24 weeks later. If the patient's HCV RNA remains not detected at the 24-week SVR assessment, he has a sustained virologic response. If it becomes detectable again, the patient has experienced relapse.">
                                </TreatmentNode>
                            </TreatmentNode>
                            <TreatmentNode Type="Parent" Value="1"
                                Label="Yes" Text="HCV RNA detected">
                                <TreatmentNode Type="Stop"
                                    Label="Treatment Stopped" Help="The patient has experienced virologic failure. By the end of Week 24, HCV RNA should not be detected. All treatment should be stopped.">
                                </TreatmentNode>
                            </TreatmentNode>
                        </TreatmentNode>
                    </TreatmentNode>
                    <TreatmentNode Type="Parent" Label="Yes" Value="1"
                        Text="HCV RNA &gt;= 1,000 IU/ml">
                        <TreatmentNode Type="Stop"
                            Label="Treatment Stopped" Help="The patient has experienced virologic failure. By the end of Week 12, HCV RNA should be suppressed to &lt;=1000 IU/ml. All treatment should be stopped.">
                        </TreatmentNode>
                    </TreatmentNode>
                </TreatmentNode>
            </TreatmentNode>
            <TreatmentNode Type="Parent" Value="1" Label="Yes"
                Text="&gt;= 1,000 IU/ml">
                <TreatmentNode Type="Stop" Label="Treatment Stopped" Help="The patient has experienced virologic failure. By the end of Week 4, HCV RNA should be suppressed to &lt;=1000 IU/ml. All treatment should be stopped.">
                </TreatmentNode>
            </TreatmentNode>
        </TreatmentNode>
    </TreatmentNode>
</TreatmentNodes>